港股異動 | 歌禮制藥-B半日收漲5.33% 擬回購最多1.12億股
格隆匯11月15日丨歌禮制藥-B(1672.HK)午間收報4.15港元,漲5.33%,暫成交1275萬港元,最新總市值46.5億港元。歌禮制藥-B昨日(14日)盤後發公告稱,公司董事會擬根據公司股東於今年6月6日舉行的公司股東周年大會上授予董事會購回公司股份的一般授權行使其權力,在合適時間於公開市場上購回公司的股份。根據購回授權,公司獲准購回最多1.12億股股份,相當於股東周年大會日期已發行股份總數的10%。有分析人士曾指,作為港交所上市政策修改後首家生物科技類公司,歌禮制藥專注於抗病毒領域的研發,業務涵蓋從新藥探索和開發直到生產和商業化的完整產業鏈。隨着公司不斷推進,有望在後續納入國家醫保目錄中而受益。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.